A Single Patient Expanded Access Treatment Plan of Low Dose Cyclophosphamide Fludarabine and Antithymocyte Globulin Followed by Related Donor Mesenchymal and Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia in a Patient with Fanconi An
Investigational Treatment Study for [Condition/Disease]
Not Recruiting
1 years - 18 years
All
Phase
N/A
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Fanconi Anemia
Age:
1 years - 18 years
Gender: All
Who can participate: Eligible participants are individuals aged [age range], diagnosed with [Condition/Disease]. Key eligibility criteria include [list key eligibility factors].
Study details: Participants will receive either the investigational treatment or a placebo, administered [method of administration]. The study involves [describe any key activities or procedures participants will undergo].
Updated on
19 Feb 2024.
Study ID: 1108006474
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
